Resistance to single‐agent chemotherapy and its risk factors in low‐risk gestational trophoblastic neoplasms

Abstract

Intermediate risk GTN patients had a higher risk of resistance to chemotherapy compared with low-risk patients. Clinical trials and cost-effectiveness studies are needed to suggest a better treatment program for the intermediate risk group.